ELZA @ APAO 2026 Hong Kong
ELZA’s CEO and CMO, Nikki and Farhad Hafezi flew to Hong Kong to attend APAO 2026, including an invited symposium presentation by Prof. Farhad Hafezi on Custom CXL.
Mark Hillen
February 9, 2026
ELZA’s CEO and CMO, Nikki and Farhad Hafezi flew to Hong Kong to attend APAO 2026, including an invited symposium presentation by Prof. Farhad Hafezi on Custom CXL.
Why early keratoconus screening in children is essential for preventing vision loss and long-term disability.
ELZA joined the SCHWIND User Meeting 2025 in Bangkok to share our insights on advanced laser eye surgery.
Nikki Hafezi expands K-MAP to Andijan, Uzbekistan, expanding keratoconus screening to the Fergana Valley.
We are proud to announce that ELZA Institute’s CEO, Nikki L. Hafezi MAS IP ETHZ, will serve as Course Director for a new international program in Uzbekistan — the “Professional Development Course in Visual Sciences and Public Health”.
Nikki Hafezi, MAS IP ETHZ led the P21 program in Bukhara, combining keratoconus screening with multidisciplinary pediatric assessments for 400 children.
In March 2025, Tashkent became the focal point for ophthalmology innovation as it hosted the Second International Conference on Innovative Technologies in Ophthalmology.
ELZA’s CEO, Nikki Hafezi launches a keratoconus screening initiative for children with Down syndrome in Uzbekistan, beginning in Andijan.
At EgSCRS, ELZA’s pyramid approach to keratoconus: ELZA-sub400, PACE, ECO-CAIRS, and AI-guided diagnostics was presented in detail.
As part of the 70th Anniversary celebration of the Andijan State Medical Institute (ASMI) in Uzbekistan, ELZA Institute CEO, Nikki Hafezi, MAS IP ETHZ, took part in a series of high-level academic and institutional events from April 28 to May 1, 2025.